Stockscreener 앱 받기
2.085
0.96%
0.015
전일 마감가:
$2.07
열려 있는:
$2.08
하루 거래량:
32,860
Relative Volume:
0.12
시가총액:
$36.04M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.48%
1개월 성능:
+0.48%
6개월 성능:
+102.90%
1년 성능:
-39.60%
1일 변동 폭
$2.07
$2.09
1주일 범위
$2.07
$2.09
52주 변동 폭
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
명칭
Mural Oncology Plc
전화
353 1 905 8020
주소
10 EARLSFORT TERRACE, DUBLIN 2
MURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.08 | 35.86M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.31 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.47 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.58 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-25 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-04-04 | 개시 | Morgan Stanley | Overweight |
Mural Oncology Plc 주식(MURA)의 최신 뉴스
Trium Capital discloses 11% stake in Mural Oncology By Investing.com - Investing.com South Africa
Trium Capital discloses 11% stake in Mural Oncology - Investing.com
Is Mural Oncology plc stock attractive for growth ETFsShare Buyback & Growth Focused Stock Reports - newser.com
What candlestick patterns are forming on Mural Oncology plcMarket Activity Report & Safe Entry Momentum Tips - newser.com
Exit strategy if you’re trapped in Mural Oncology plc2025 Key Lessons & Low Risk High Win Rate Stock Picks - newser.com
Visualizing Mural Oncology plc stock with heatmapsMarket Risk Report & Capital Efficiency Focused Ideas - newser.com
Does Mural Oncology plc qualify in momentum factor screeningPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Citadel Group discloses 1.35% position in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.35% position in Mural Oncology - Investing.com India
Combining machine learning predictions for Mural Oncology plcEarnings Recap Summary & Fast Entry High Yield Tips - newser.com
What recovery options are there for Mural Oncology plcJuly 2025 PreEarnings & Precise Buy Zone Identification - newser.com
Citadel Group discloses 1.34% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.34% stake in Mural Oncology - Investing.com
Citadel Group discloses 1.33% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.33% stake in Mural Oncology - Investing.com
Detecting support and resistance levels for Mural Oncology plc2025 Sector Review & Technical Analysis for Trade Confirmation - newser.com
What MACD signals say about Mural Oncology plcJuly 2025 Technicals & Safe Capital Growth Plans - newser.com
Visual trend scoring systems applied to Mural Oncology plc2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Will Mural Oncology plc outperform the marketMarket Activity Recap & Precise Buy Zone Tips - newser.com
News impact scoring models applied to Mural Oncology plcQuarterly Profit Report & Fast Entry Momentum Trade Alerts - newser.com
Will Mural Oncology plc continue its uptrendWeekly Investment Summary & AI Optimized Trade Strategies - newser.com
Quantitative breakdown of Mural Oncology plc recent moveQuarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com
Is Mural Oncology plc stock undervalued vs historical averagesTrade Ideas & Risk Managed Investment Entry Signals - newser.com
Cancer stocks rebound, outpacing broader markets in Q3 2025 - BioWorld MedTech
Citadel Group discloses 1.32% stake in Mural Oncology By Investing.com - Investing.com Canada
Citadel Group discloses 1.32% stake in Mural Oncology - Investing.com India
Citadel Group discloses 1.56% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.56% stake in Mural Oncology - Investing.com India
Mural Oncology Plc (MURA) 재무 분석
Mural Oncology Plc (MURA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Mural Oncology Plc 주식 (MURA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Keson-Brookes Maiken | See Remarks |
Jul 18 '25 |
Sale |
2.48 |
2,158 |
5,352 |
71,406 |
1.12%
자본화:
|
볼륨(24시간):